Health Care & Life Sciences » Pharmaceuticals | Daihan Pharmaceutical Co. Ltd.

Daihan Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
106,803
111,709
124,276
139,437
144,439
Cost of Goods Sold (COGS) incl. D&A
76,588
77,616
84,634
96,026
89,877
Gross Income
30,215
34,093
39,642
43,411
54,563
SG&A Expense
17,631
20,151
20,954
21,690
22,309
EBIT
12,584
13,942
18,688
21,721
31,661
Unusual Expense
2,248
-
-
-
-
Non Operating Income/Expense
478
338
590
111
686
Interest Expense
373
550
574
437
351
Pretax Income
9,615
13,165
17,660
21,286
32,053
Income Tax
1,843
2,744
3,884
3,628
7,221
Consolidated Net Income
7,771
10,420
13,776
17,657
24,832
Net Income
7,771
10,420
13,776
17,657
24,832
Net Income After Extraordinaries
7,771
10,420
13,776
17,657
24,832
Net Income Available to Common
7,771
10,420
13,776
17,657
24,832
EPS (Basic)
1,297.00
1,737.00
2,296.00
2,943.00
4,139.00
Basic Shares Outstanding
6
6
6
6
6
EPS (Diluted)
1,297.34
1,736.73
2,296.04
2,942.88
4,138.73
Diluted Shares Outstanding
6
6
6
6
6
EBITDA
16,110
17,928
23,179
26,794
39,249
Other Operating Expense
-
-
-
-
593
Non-Operating Interest Income
131
111
136
112
58

About Daihan Pharmaceutical Co.

View Profile
Address
3 Seonyu-ro 45-gil
Seoul SL 07209
Korea, Republic Of
Employees -
Website http://www.daihan.com
Updated 09/14/2018
Daihan Pharmaceutical Co., Ltd. manufactures medical products. It operates through the following businesses: Manufacturing, Sales & Marketing, Research & Development, Quality Control and Overseas Business. Its Manufacturing business provides manufactures medicinal products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.